home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

19 rows where docket_id = "FDA-2026-P-4885" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)

document_type 2

  • Supporting & Related Material 17
  • Other 2

posted_year 1

  • 2026 19

agency_id 1

  • FDA 19
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-P-4885-0005 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Reference 2 - 21 USC 353 prescription drugs Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:43:59Z   0 0 09000064b92c40c7
FDA-2026-P-4885-0014 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Reference 11 - CDC national diabetes statistics report webpage copy Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:44:28Z   0 0 09000064b92c550e
FDA-2026-P-4885-0015 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Reference 12 - CDC CKD factsheet 2026 Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:44:31Z   0 0 09000064b92c550f
FDA-2026-P-4885-0006 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Reference 3 - 21 CFR 310 200 prescription exemption Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:44:02Z   0 0 09000064b92c5506
FDA-2026-P-4885-0007 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Reference 4 - FDA Rx to OTC switches webpage copy Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:44:04Z   0 0 09000064b92c5507
FDA-2026-P-4885-0003 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Appendix A Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:43:52Z   0 0 09000064b92c75db
FDA-2026-P-4885-0017 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Reference 14 - CDC chronic disease costs fast facts webpage copy Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:44:38Z   0 0 09000064b92c5511
FDA-2026-P-4885-0004 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Reference 1 - 21 CFR 10 30 citizen petition Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:43:55Z   0 0 09000064b92c40c6
FDA-2026-P-4885-0012 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Reference 9 - CDC high blood pressure interventions webpage copy Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:44:22Z   0 0 09000064b92c550c
FDA-2026-P-4885-0010 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Reference 7 - DEA controlled substances alpha order Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:44:16Z   0 0 09000064b92c550a
FDA-2026-P-4885-0001 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Citizen Petition from David Behar Other Citizen Petition 2026-05-06T04:00:00Z 2026 5 2026-05-06T04:00:00Z   2026-05-06T22:43:37Z   1 0 09000064b92c4ef5
FDA-2026-P-4885-0002 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Acknowledgement Letter from FDA DMB to David Behar Other Acknowledgement Letter/Receipt 2026-05-06T04:00:00Z 2026 5 2026-05-06T04:00:00Z   2026-05-06T22:43:44Z   0 0 09000064b92c4ef8
FDA-2026-P-4885-0011 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Reference 8 - AMN 2025 physician appointment wait times Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:44:19Z   0 0 09000064b92c550b
FDA-2026-P-4885-0008 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Reference 5 - FDA prescription to nonprescription switch list webpage copy Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:44:08Z   0 0 09000064b92c5508
FDA-2026-P-4885-0013 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Reference 10 - NCHS data brief 511 hypertension 2024 Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:44:26Z   0 0 09000064b92c550d
FDA-2026-P-4885-0018 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Reference 15 - Farley 2010 preventive services citation copy Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:44:42Z   0 0 09000064b92c5512
FDA-2026-P-4885-0019 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Reference 16 - 21 CFR 25 30 categorical exclusion Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:44:45Z   0 0 09000064b92c5513
FDA-2026-P-4885-0009 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Reference 6 - FDA ACNU final rule 2024 Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:44:11Z   0 0 09000064b92c5509
FDA-2026-P-4885-0016 FDA Requests that the FDA initiate rulemaking and related administrative action to place non-abused human drugs over the counter. "Non-abused" means human drugs that are not scheduled under the Controlled Substances Act and are not currently marketed as controlled substances. FDA-2026-P-4885 Reference 13 - CDC high cholesterol facts webpage copy Supporting & Related Material Background Material 2026-05-06T04:00:00Z 2026 5     2026-05-06T22:44:35Z   0 0 09000064b92c5510

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 24.277ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API